Table 1 Overview of donor and preservation data of the study population
Total livers included | n = 34 |
Gender | Female n = 18, male n = 16 |
Donor agea (years) | 62 (52.25–70) |
Donor type | DBD n = 25, DCD n = 9 |
ECD | Yes n = 28, no n = 6 |
CITa (h) | 5.91 (4.70–7.69) |
NMP timea (h) | 19.13 (11.56–21.64) |
Total preservation timea (h) | 25.45 (18.08–27.62) |
Transplantation after NMP | Yes n = 26, no n = 8 |
Livers included for scRNASeq | n = 8 |
Gender | Female n = 5, male n = 3 |
Donor agea (years) | 66 (53 – 70.5) |
Donor type | DBD n = 7, DCD n = 1 |
ECD | Yes n = 6, no n = 2 |
CITa (h) | 5.31 (4.41–5.8) |
NMP timea (h) | 18.08 (13.15–20.08) |
Total preservation timea (h) | 22.46 (19.55–25.66) |
Transplantation after NMP | Yes n = 6, no n = 2 |
Livers included for perfusate analysis | n = 26 |
Gender | Female n = 15, male n = 11 |
Donor agea (years) | 60.5 (52.25–67.50) |
Donor type | DBD n = 18, DCD n = 8 |
ECD | Yes n = 22, no n = 4 |
CITa (h) | 6.13 (4.94–7.77) |
NMP timea (h) | 19.88 (11.02–21.64) |
Total preservation timea (h) | 26.07 (17.65–28.86) |
Transplantation after NMP | Yes n = 18, no n = 8 |
